Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (111-120 of 752) with videos related to

Pageof 76
Sort By:
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 13, 2020
Copeptin combined with either non-high sensitivity or high sensitivity cardiac troponin for instant rule-out of suspected non-ST segment elevation myocardial infarctionEvangelos Giannitsis, Anna Slagman, Christian W Hamm, et al.
Thrombosis and Haemostasis|February 16, 2005
The adaptive immune system and long-term outcome in patients with stable coronary disease. Predictive value of routine laboratory measurementsAlexander Niessner, Senta Graf, Mariam Nikfardjam, et al.
Biomedicines|May 28, 2022
New Treatment Targets and Innovative Lipid-Lowering Therapies in Very-High-Risk Patients with Cardiovascular DiseaseAchim Leo Burger, Edita Pogran, Marie Muthspiel, et al.
Journal of Electrocardiology|April 23, 2011
Assessment of repolarization heterogeneity for prediction of mortality in cardiovascular disease: peak to the end of the T wave interval and nondipolar repolarization componentsPeter Smetana, Anna Schmidt, Markus Zabel, et al.
Wiener Klinische Wochenschrift|January 27, 2006
[Direct and indirect antithrombins in acute coronary syndromes]Thomas Höchtl, Alexander Geppert, Michael Nürnberg, et al.
Thrombosis and Haemostasis|December 30, 2022
Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalationFreek W A Verheugt, Kurt Huber, Peter Clemmensen, et al.
Critical Care Medicine|March 11, 2003
Plasma concentrations of von Willebrand factor and intracellular adhesion molecule-1 for prediction of outcome after successful cardiopulmonary resuscitationAlexander Geppert, Gerlinde Zorn, Georg Delle-Karth, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|November 27, 2009
Diabetes as a coronary artery disease risk equivalent: before a change of paradigm?Christoph H Saely, Stefan Aczel, Lorena Koch, et al.
Thrombosis Research|April 8, 2003
Hemostatic markers with bolus versus prolonged heparin after carotid artery stentingSabine Steiner, Ramazanali Ahmadi, Andrea Willfort, et al.
European Heart Journal. Case Reports|January 14, 2022
Multisystem inflammatory syndrome in adults in a young male following severe acute respiratory syndrome coronavirus-2 infection: a case reportChristoph C Kaufmann, Alexander Simon, David Reinhart-Mikocki, et al.
Pageof 76

Showing results (111-120 of 752) with videos related to

Sort By:
Pageof 76
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 13, 2020
Copeptin combined with either non-high sensitivity or high sensitivity cardiac troponin for instant rule-out of suspected non-ST segment elevation myocardial infarctionEvangelos Giannitsis, Anna Slagman, Christian W Hamm, et al.
Thrombosis and Haemostasis|February 16, 2005
The adaptive immune system and long-term outcome in patients with stable coronary disease. Predictive value of routine laboratory measurementsAlexander Niessner, Senta Graf, Mariam Nikfardjam, et al.
Biomedicines|May 28, 2022
New Treatment Targets and Innovative Lipid-Lowering Therapies in Very-High-Risk Patients with Cardiovascular DiseaseAchim Leo Burger, Edita Pogran, Marie Muthspiel, et al.
Journal of Electrocardiology|April 23, 2011
Assessment of repolarization heterogeneity for prediction of mortality in cardiovascular disease: peak to the end of the T wave interval and nondipolar repolarization componentsPeter Smetana, Anna Schmidt, Markus Zabel, et al.
Wiener Klinische Wochenschrift|January 27, 2006
[Direct and indirect antithrombins in acute coronary syndromes]Thomas Höchtl, Alexander Geppert, Michael Nürnberg, et al.
Thrombosis and Haemostasis|December 30, 2022
Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalationFreek W A Verheugt, Kurt Huber, Peter Clemmensen, et al.
Critical Care Medicine|March 11, 2003
Plasma concentrations of von Willebrand factor and intracellular adhesion molecule-1 for prediction of outcome after successful cardiopulmonary resuscitationAlexander Geppert, Gerlinde Zorn, Georg Delle-Karth, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|November 27, 2009
Diabetes as a coronary artery disease risk equivalent: before a change of paradigm?Christoph H Saely, Stefan Aczel, Lorena Koch, et al.
Thrombosis Research|April 8, 2003
Hemostatic markers with bolus versus prolonged heparin after carotid artery stentingSabine Steiner, Ramazanali Ahmadi, Andrea Willfort, et al.
European Heart Journal. Case Reports|January 14, 2022
Multisystem inflammatory syndrome in adults in a young male following severe acute respiratory syndrome coronavirus-2 infection: a case reportChristoph C Kaufmann, Alexander Simon, David Reinhart-Mikocki, et al.
Pageof 76